Patients CinCor Pharma: A small pharma’s journey to acquisition In this week's podcast, pharmaphorum welcomes Marc de Garidel, CEO of CinCor Pharma.
News AstraZeneca bolts on blood pressure drug with CinCor takeove... AstraZeneca has extended its cardiorenal pipeline with a $1.3 billion acquisition of CinCor Pharma, adding a late-stage blood pressure-lowering drug.
News FDA finally okays Novavax's COVID-19 jab, with restrictions The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.